Corcept Therapeutics Inc. (CORT) — Analysis Summary
Corcept Therapeutics Inc. (CORT) has a market cap of $7.46B with year-over-year revenue growth of +12.8%. Net margin stands at 13.1%. The stock trades at a P/E ratio of 157.6.
Key Takeaways
- Revenue changed +12.8% year-over-year
- Net margin of 13.1%
- P/E ratio of 157.6
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, CORT posted revenue growth of +12.8% and trades at a P/E of 157.6.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.